KIM-161 upregulated the activity of checkpoint kinase 2 (Chk-2), a kinase that responds to cellular stress in HL60 (a p53-negative cancer cell) (Wolf and Rotter, 1985; van Jaarsveld et al., 2020). The gene discussed is TP53; the disease is cancer.